162 related articles for article (PubMed ID: 37185774)
1. Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm.
Romero-Caballero MD; Miralles de Imperial-Ollero JA; Sarabia-Marín E; Villegas-Pérez MP
Int Ophthalmol; 2023 Aug; 43(8):2731-2736. PubMed ID: 37185774
[TBL] [Abstract][Full Text] [Related]
2. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
4. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
[TBL] [Abstract][Full Text] [Related]
5. [Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].
Yabiku MM; Sartori Jde F; Sarraff EP; Osaki TH; Hossaka SK; Pereira CI; Freitas Wd; Osaki MH; Cariello AJ
Arq Bras Oftalmol; 2011; 74(6):414-6. PubMed ID: 22331113
[TBL] [Abstract][Full Text] [Related]
6. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin therapy for focal dystonia].
Hahn K; Niklai E; Garzuly F; Szupera Z
Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
[TBL] [Abstract][Full Text] [Related]
8. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
Bayraktar Bilen N; Bilen Ş; Topçu Yılmaz P; Evren Kemer Ö
Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
[TBL] [Abstract][Full Text] [Related]
9. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
Dutton JJ
Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
Tan AK
Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
[TBL] [Abstract][Full Text] [Related]
12. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
[TBL] [Abstract][Full Text] [Related]
13. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
Bastola P; Chaudhary M; Agrawal JP; Shah DN
Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
[TBL] [Abstract][Full Text] [Related]
14. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
Price J; Farish S; Taylor H; O'Day J
Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Injection Botulinum Toxin in Blepharospasm.
Amatya M; Limbu B; Sthapit PR; Gurung HB; Saiju R
Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
[TBL] [Abstract][Full Text] [Related]
16. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A in blepharospasm and hemifacial spasm.
Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
[TBL] [Abstract][Full Text] [Related]
19. Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
Park YC; Lim JK; Lee DK; Yi SD
J Korean Med Sci; 1993 Oct; 8(5):334-40. PubMed ID: 8305141
[TBL] [Abstract][Full Text] [Related]
20. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
Costa PG; Cardoso IP; Saraiva FP; Raiza AC; Tanaka LK; Matayoshi S
Arq Bras Oftalmol; 2006; 69(3):319-22. PubMed ID: 16936952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]